Company Number: 14074978

Analysis Date: 2025-07-29 19:03 UTC

Financial Health Assessment for APOTHECO SHOP LIMITED

---

1. Financial Health Score: D

Explanation:
The company shows significant signs of financial distress, primarily due to persistent negative net assets and worsening working capital deficits. Despite being a relatively new micro-entity, the balance sheet indicates critical challenges in liquidity and solvency, warranting a low grade.

---

2. Key Vital Signs

Metric	2024 Value (£)	Interpretation
Fixed Assets	4,114	Modest investment in long-term assets appropriate for micro size.
Current Assets	4,158	Low liquid assets available to meet short-term obligations.
Current Liabilities	32,745	High short-term debts, significantly exceeding current assets.
Net Current Assets (Working Capital)	-26,733	Negative, indicating inability to cover short-term liabilities.
Net Assets (Shareholders' Funds)	-22,619	Negative equity, showing cumulative losses or high liabilities.
Employee Count	6	Growth from 2 to 6 employees suggests operational expansion.

Interpretation of Vital Signs:

• Negative Working Capital: A "symptom of distress" where current liabilities far outstrip current assets, signaling potential liquidity problems.
• Negative Net Assets: Indicates the company’s total liabilities exceed its total assets, an alarming "diagnostic marker" for possible insolvency risks.
• Employee Growth: While expansion can be positive, increasing staff without strong financial backing may strain resources further.

---

3. Diagnosis

APOTHECO SHOP LIMITED is currently exhibiting clear signs of financial strain:

• The company's balance sheet "vital signs" reveal a weakening financial position, with net liabilities deepening from -£10,063 in 2023 to -£22,619 in 2024.
• Negative working capital of -£26,733 suggests the company may struggle to meet its short-term obligations without additional financing or operational improvements.
• The increase in current liabilities (~£10k increase year-on-year) amid declining current assets signals worsening liquidity.
• The company remains active and has not breached filing deadlines, indicating compliance discipline, but financial resilience is low.
• Absence of an audit (due to micro-entity status) limits detailed insight into profitability, but negative equity strongly suggests cumulative losses or capital erosion.
• The directors have seen changes recently, with one director resigning, which could indicate internal transitions.

In summary, the company exhibits "symptoms of financial distress" that, if unaddressed, might lead to solvency issues.

---

4. Recommendations

To improve financial wellness and restore health, the company should consider:

1. Strengthen Liquidity:

   • Seek short-term financing or credit lines to cover immediate liabilities and improve working capital.
   • Review and optimize cash flow management, accelerating receivables and controlling payables.

2. Cost Management and Operational Efficiency:

   • Evaluate staffing levels and operational costs to align expenses with revenue generation capacity.
   • Assess fixed asset utilization to avoid unnecessary capital lock-in.

3. Capital Injection:

   • Consider equity funding, whether through existing shareholders increasing capital or new investors, to restore positive net assets.
   • Explore grants or support schemes for micro-businesses to bolster financial position.

4. Business Model Review:

   • Analyze product/service profitability and market positioning to enhance revenue streams.
   • Implement strategic initiatives to boost sales and reduce dependency on credit.

5. Governance and Monitoring:

   • Maintain rigorous financial monitoring and forecasting to identify early warning signs.
   • Engage with financial advisors for tailored restructuring or turnaround strategies.

---